Logo image of ACVA

ACV AUCTIONS INC-A (ACVA) Stock Fundamental Analysis

NASDAQ:ACVA - Nasdaq - US00091G1040 - Common Stock - Currency: USD

14.11  -0.06 (-0.42%)

After market: 14.11 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ACVA. ACVA was compared to 83 industry peers in the Commercial Services & Supplies industry. The financial health of ACVA is average, but there are quite some concerns on its profitability. ACVA is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ACVA has reported negative net income.
In the past year ACVA had a positive cash flow from operations.
ACVA had negative earnings in each of the past 5 years.
In multiple years ACVA reported negative operating cash flow during the last 5 years.
ACVA Yearly Net Income VS EBIT VS OCF VS FCFACVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.10%, ACVA is doing worse than 77.38% of the companies in the same industry.
The Return On Equity of ACVA (-18.11%) is worse than 70.24% of its industry peers.
Industry RankSector Rank
ROA -8.1%
ROE -18.11%
ROIC N/A
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ACVA Yearly ROA, ROE, ROICACVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 52.22%, ACVA belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
In the last couple of years the Gross Margin of ACVA has grown nicely.
The Profit Margin and Operating Margin are not available for ACVA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
ACVA Yearly Profit, Operating, Gross MarginsACVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

5

2. Health

2.1 Basic Checks

ACVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACVA has more shares outstanding
ACVA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACVA has a worse debt to assets ratio.
ACVA Yearly Shares OutstandingACVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACVA Yearly Total Debt VS Total AssetsACVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.55 indicates that ACVA is not a great score, but indicates only limited risk for bankruptcy at the moment.
ACVA has a Altman-Z score (2.55) which is comparable to the rest of the industry.
The Debt to FCF ratio of ACVA is 3.95, which is a good value as it means it would take ACVA, 3.95 years of fcf income to pay off all of its debts.
ACVA has a Debt to FCF ratio of 3.95. This is in the better half of the industry: ACVA outperforms 67.86% of its industry peers.
ACVA has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
ACVA's Debt to Equity ratio of 0.28 is fine compared to the rest of the industry. ACVA outperforms 65.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 3.95
Altman-Z 2.55
ROIC/WACCN/A
WACC8.63%
ACVA Yearly LT Debt VS Equity VS FCFACVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 1.56 indicates that ACVA should not have too much problems paying its short term obligations.
ACVA has a Current ratio (1.56) which is comparable to the rest of the industry.
A Quick Ratio of 1.56 indicates that ACVA should not have too much problems paying its short term obligations.
ACVA has a Quick ratio of 1.56. This is in the better half of the industry: ACVA outperforms 67.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56
ACVA Yearly Current Assets VS Current LiabilitesACVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

7

3. Growth

3.1 Past

ACVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.32%.
Looking at the last year, ACVA shows a very strong growth in Revenue. The Revenue has grown by 32.42%.
ACVA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.93% yearly.
EPS 1Y (TTM)-26.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
Revenue 1Y (TTM)32.42%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%34.75%

3.2 Future

The Earnings Per Share is expected to grow by 52.66% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 22.31% on average over the next years. This is a very strong growth
EPS Next Y61.36%
EPS Next 2Y63.97%
EPS Next 3Y67.83%
EPS Next 5Y52.66%
Revenue Next Year22.37%
Revenue Next 2Y23.41%
Revenue Next 3Y23.95%
Revenue Next 5Y22.31%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ACVA Yearly Revenue VS EstimatesACVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
ACVA Yearly EPS VS EstimatesACVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 2 3 4 5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACVA. In the last year negative earnings were reported.
Also next year ACVA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACVA Price Earnings VS Forward Price EarningsACVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

ACVA's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. ACVA is more expensive than 60.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 76.43
EV/EBITDA N/A
ACVA Per share dataACVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as ACVA's earnings are expected to grow with 67.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y63.97%
EPS Next 3Y67.83%

More info and screens

0

5. Dividend

5.1 Amount

ACVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACV AUCTIONS INC-A

NASDAQ:ACVA (3/7/2025, 8:03:30 PM)

After market: 14.11 0 (0%)

14.11

-0.06 (-0.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-06 2025-05-06
Inst Owners105.03%
Inst Owner Change6.44%
Ins Owners2.1%
Ins Owner Change12.85%
Market Cap2.38B
Analysts81
Price Target24.79 (75.69%)
Short Float %5.85%
Short Ratio5.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.6%
Min EPS beat(2)-9.21%
Max EPS beat(2)14.41%
EPS beat(4)2
Avg EPS beat(4)-4.28%
Min EPS beat(4)-30.72%
Max EPS beat(4)14.41%
EPS beat(8)6
Avg EPS beat(8)16.15%
EPS beat(12)9
Avg EPS beat(12)13.85%
EPS beat(16)13
Avg EPS beat(16)18.38%
Revenue beat(2)1
Avg Revenue beat(2)2.23%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)4.71%
Revenue beat(4)2
Avg Revenue beat(4)1.12%
Min Revenue beat(4)-0.78%
Max Revenue beat(4)4.71%
Revenue beat(8)4
Avg Revenue beat(8)1.29%
Revenue beat(12)5
Avg Revenue beat(12)0.57%
Revenue beat(16)9
Avg Revenue beat(16)4.34%
PT rev (1m)-1.93%
PT rev (3m)-2.92%
EPS NQ rev (1m)-106.51%
EPS NQ rev (3m)-137.42%
EPS NY rev (1m)-8.01%
EPS NY rev (3m)-38.89%
Revenue NQ rev (1m)-1.22%
Revenue NQ rev (3m)-2.69%
Revenue NY rev (1m)-0.99%
Revenue NY rev (3m)-1.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.74
P/FCF 76.43
P/OCF 36.41
P/B 5.41
P/tB 23.78
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)0.18
FCFY1.31%
OCF(TTM)0.39
OCFY2.75%
SpS3.78
BVpS2.61
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.1%
ROE -18.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.22%
FCFM 4.89%
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 3.95
Debt/EBITDA N/A
Cap/Depr 93.03%
Cap/Sales 5.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z 2.55
F-Score5
WACC8.63%
ROIC/WACCN/A
Cap/Depr(3y)148.24%
Cap/Depr(5y)145.57%
Cap/Sales(3y)5.59%
Cap/Sales(5y)4.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
EPS Next Y61.36%
EPS Next 2Y63.97%
EPS Next 3Y67.83%
EPS Next 5Y52.66%
Revenue 1Y (TTM)32.42%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%34.75%
Revenue Next Year22.37%
Revenue Next 2Y23.41%
Revenue Next 3Y23.95%
Revenue Next 5Y22.31%
EBIT growth 1Y12.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year197.17%
EBIT Next 3Y75.01%
EBIT Next 5Y51.44%
FCF growth 1Y167.65%
FCF growth 3Y-24.1%
FCF growth 5YN/A
OCF growth 1Y465.65%
OCF growth 3Y-8.47%
OCF growth 5YN/A